Home     Profile     Vaginitis     WH-1 Capsule     Safety & Efficacy     Clinical Trials     Business Opportunity     Contact
WH-1 A Breakthrough in the Treatment of Vaginitis
(White discharge in women)
WH-1 is an Ayurvedic Herbal Formula developed by
Dr. V.R. Bapat, Bangalore, India. For his profile click here
He has experience of treating with this formulation over
a period of 35 years in his clinical practice.

Advantages WH-1 Treatment

Single drug useful in White Discharge caused by multiple pathogens such as Bacteria, Yeast, and Trichomonas.
Useful in mixed infections
Useful in white discharge in pregnancy
Helps growth of normal vaginal flora and lactobacillus
No superimposed infection as seen in modern medicine
No adverse effects. Very safe
Cost Effective
   
 

WH-1 Capsule - a simple alternative Option

 
   
 

WH-1 is an ayurvedic herbal formula developed by Dr. V.R. Bapat, Bangalore . India . For his profile click here . He has experience of treating with this formulation over a period of 35 years in his clinical practice.

Safety and Efficacy

Safety :
Acute oral LD50 toxicity study of test drug WH-1 conducted on rats showed no treatment related toxic signs and symptoms. The study was conducted as per OECD guidelines. The raw materials and finished product have been tested for heavy metals and microbial contents. In a study conducted in St. John's Medical College and Hospital Bangalore on 41 female patients, assessment of safety of the drug was done through biochemical parameters. Random Blood Sugar, Kidney Function Test and Liver Function Tests were conducted prior to and after treatment. There was no biological evidence of side effects with WH-1 treatment.

Efficacy : The second clinical trial was conducted in St. John's Medical College and Hospital, Bangalore. (Click here for full text.) This was a study to compare the safety and efficacy of WH-1 capsule with standard drugs of FAS-3 Kit and Fluconazole. The following are the observations of the authors:

  • The important efficacy parameters such as microbiological as well as clinical examination showed that WH-1 is equipotent to standard therapy. It is reported that the combination of antibacterial, antifungal and antiprotozoal agents in the modern therapy alter the normal vaginal flora leading to super infection and /or Increased chances of Recurrent infection. Interestingly, the present test preparation WH-1 showed absence of such associated complications.
  • To conclude, our study confirms the observations of the previous preliminary study reports. WH-1 was found to be equally efficacious as standard drugs of FAS-3 Kit and Fluconazole in mixed infection, nonspecific vaginitis as well as vaginal candidiasis. Adverse effects were higher in standard treatment group. Certain positive findings of the present study with WH-1 were its global utility in the treatment of Vaginitis/Vaginosis caused by multiple pathogens, minor incidence of adverse drug reactions, increment in lactobacilli count, and 100% compliance despite longer duration of treatment. There was no biochemical evidence of side effects with WH-1 regimen. WH-1 can therefore be considered to be an effective and safe option for treatment of vaginitis/Vaginosis.
   
 
 
 
 
 
 
 
 
Copyright © reserved for Dr. V.R. Bapat